Craniofacial Microsomia: Accelerating Understanding of the Significance and Etiology
NCT04351893
Bone Diseases, Bone Diseases, Developmental
Los Angeles, California, United States
View Trial DetailsNCT Number: NCT04056858
The aim of this study is to identify of the first gene involved in the Goldenhar syndrome in a cohort of 120 affected patients.
Looking for future studies?
Notify MeAll sexes
Observational
Goldenhar syndrome belongs to the heterogeneous spectrum of oculoauriculovertebral dysplasia. Several chromosomal abnormalities have been described associated with this spectrum, and furthermore mutations in different genes of development cause abnormalities of the jaw or facial asymmetries in human or mouse. To date, no gene has been identified as formally involved in the genesis of the OAVS, despite evidence of familial cases, mostly with autosomal dominant inheritance.
The aim of this study is to identify of the first gene involved in the Goldenhar syndrome in a cohort of 120 affected patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: At the screening
Identification of the first gene involved in Goldenhar syndrome
University Hospital, Bordeaux
Other
Identification and Investigation of a Gene Involved in Monogenic Forms of Goldenhar Syndrome.
Acronym: GOLDGEN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04351893
Bone Diseases, Bone Diseases, Developmental
Los Angeles, California, United States
View Trial DetailsNCT02224677
Bone Diseases, Bone Diseases, Developmental
Los Angeles, California, United States
View Trial DetailsNCT04931056
Acrofacial dysostosis, Nager type, Bone Diseases
Salta, Argentina
View Trial DetailsNCT03806361
Bone Diseases, Bone Diseases, Developmental
São Paulo, Brazil
View Trial Details